Pearl River Capital, LLC Mirati Therapeutics, Inc. Transaction History

Pearl River Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$75.82 - $150.97 $243,382 - $484,613	-3,210 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$132.01 - $190.29 $423,752 - $610,830	3,210 New	3,210 $471,000
Q2 2019 Aug 12, 2019	SELL	$59.49 - $104.71 $4,045 - $7,120	-68 Closed	0 $0
Q1 2019 May 02, 2019	SELL	$43.65 - $78.95 $1,833 - $3,315	-42 Reduced 38.18%	68 $4,000
Q4 2018 Feb 08, 2019	BUY	$32.0 - $47.43 $3,520 - $5,217	110 New	110 $5,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.